PAVmed Inc. - Common Stock (PAVM)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 1,403% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -1,807.8%
- Revenue declining 98% annually
PAVmed Inc. - Common Stock (PAVM) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $42 million . Key value metrics: P/E ratio 25.9, P/B ratio 5.20, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
PAVmed Inc. - Common Stock — Fundamental Analysis Summary
PAVmed Inc. - Common Stock (PAVM) is currently trading 1,403% above its Graham Number of $0.38, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 25.9x.
On financial health, PAVM shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -1,807.8% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.38.
StockPik's composite Value Score for PAVM is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PAVM reports a thin gross margin of -458.5% (sector average: 39.4%) and a negative operating margin of -56,195.1%.
PAVM shows revenue declining at 98% year-over-year, with earnings declining at 99%.